Neogenomics Inc (NEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,535 | 1,132 | 2,033 | 65 | -1,177 |
| Depreciation Amortization | 7,142 | 5,706 | 4,461 | 3,856 | 2,125 |
| Accounts receivable | -3,215 | -2,770 | -7,416 | -9,192 | -5,226 |
| Other Working Capital | -1,945 | -517 | -7,993 | -8,264 | -3,904 |
| Other Operating Activity | 6,946 | 5,899 | 11,142 | 13,043 | 8,251 |
| Operating Cash Flow | $6,393 | $9,450 | $2,227 | $-492 | $69 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,215 | -3,772 | -2,011 | -2,615 | -897 |
| Net Acquisitions | -72,940 | -5,830 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,037 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -1,037 | 0 |
| Investing Cash Flow | $-75,155 | $-9,602 | $-2,011 | $-3,652 | $-897 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,002 | -4,282 | -4,177 | 4,560 | 456 |
| Debt Issued | 55,022 | N/A | N/A | N/A | N/A |
| Debt Repayment | -4,115 | -3,581 | -2,606 | -2,187 | -1,579 |
| Common Stock Issued | 935 | 36,870 | 9,533 | 511 | 3,482 |
| Other Financing Activity | -3,351 | 0 | 0 | 500 | 0 |
| Financing Cash Flow | $58,493 | $29,007 | $2,750 | $3,384 | $2,359 |
| Beginning Cash Position | 33,689 | 4,834 | 1,868 | 2,628 | 1,097 |
| End Cash Position | 23,420 | 33,689 | 4,834 | 1,868 | 2,628 |
| Net Cash Flow | $-10,269 | $28,855 | $2,966 | $-760 | $1,531 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,393 | 9,450 | 2,227 | -492 | 69 |
| Capital Expenditure | -2,215 | -3,772 | -2,011 | -2,615 | -897 |
| Free Cash Flow | 4,178 | 5,678 | 216 | -3,107 | -828 |